within the speedily evolving subject of oncology research, precise and efficient mutation screening is critical for producing targeted therapies. The KRAS products and services Platform plays a pivotal part On this landscape by offering comprehensive remedies for KRAS mutation profiling and analysis. KRAS mutations, located in roughly ninety five%